WWOX induces apoptosis and inhibits proliferation in cervical cancer and cell lines

Qu,Junjie; Lu,Wen; Li,Bilan; Lu,Cong; Wan,Xiaoping

doi:10.3892/ijmm.2013.1314

WWOX induces apoptosis and inhibits proliferation in cervical cancer and cell lines

Authors:
- Junjie Qu
- Wen Lu
- Bilan Li
- Cong Lu
- Xiaoping Wan
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, The International Peace Maternity and Child Health Hospital of China Welfare Institute affiliated with Shanghai Jiao Tong University, Shanghai 200032, P.R. China, Shanghai First People's Hospital, Shanghai 200080, P.R. China
Published online on: March 21, 2013 https://doi.org/10.3892/ijmm.2013.1314
Pages: 1139-1147

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cervical cancer is the second most common gynecological malignancy, but the molecular events involved in its development remain unclear. The tumor‑suppressor gene, WW domain-containing oxidoreductase (WWOX), has been found to be lost in various types of cancers. Few studies have been reported detailing the function of WWOX in human cervical cancer; therefore we aimed to investigate the role played by WWOX in human cervical cancer. Immunohistochemistry was used to study preinvasive and invasive primary cervical cancer. Full length cDNA was transfected into HeLa cells to overexpress WWOX, and short hairpin RNA (shRNA) was transfected into SiHa cells to deplete its expression, respectively. The cellular levels of WWOX RNA and protein were detected by real-time PCR and western immunoblotting. Proliferation rates were assessed by methyl thiazolyl tetrazolium (MTT), plate colony formation and soft agar colony assays. Cellular apoptosis was measured by flow cytometry and TdT-mediated dUTP nick-end labeling (TUNEL) assay. The activity of caspase-3 and its protein levels were determined by caspase-3 activity assay and western blot analysis. Xenografts were established by injecting cells into nude mice. The results showed that WWOX expression was decreased in human cervical cancer and cervical cancer cell lines. Reconstitution of WWOX in HeLa cells inhibited their proliferation and induced apoptosis, while knockdown of WWOX in SiHa cells promoted proliferation and inhibited apoptosis. Xenografts in groups of mice verified the effect in vivo. These data suggest that underexpression of WWOX is associated with cervical cancer development. Modulation of WWOX expression may be an effective and novel method for the treatment of cervical cancer.

View Figures

View References

1	Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
2	Mayrand MH, Duarte-Franco E, Rodrigues I, et al: Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 357:1579–1588. 2007. View Article : Google Scholar : PubMed/NCBI
3	Kent A: HPV vaccination and testing. Rev Obstet Gynecol. 3:33–34. 2010.
4	Wang Y, Chen J, Zhang W, Hong W and Yu F: Study of the prevalence of human Papillomavirus infection in Chinese women with cervical cancer. Afr J Microbiol Res. 6:1048–1053. 2012.
5	Aleyamma M and Preethi SG: Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix - worldwide. Asian Pac J Cancer Prev. 10:645–650. 2009.PubMed/NCBI
6	Misson DR, Abdalla DR, Borges AM, et al: Cytokine serum levels in patients with cervical intraepithelial neoplasia grade II-III treated with intralesional interferon-α 2b. Tumori. 97:578–584. 2011.PubMed/NCBI
7	Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA and Aldaz CM: WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res. 60:2140–2145. 2000.
8	Del Mare S, Salah Z and Aqeilan RI: WWOX: its genomics, partners, and functions. J Cell Biochem. 108:737–745. 2009.PubMed/NCBI
9	Aqeilan RI, Hagan JP, de Bruin A, et al: Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis. Endocrinology. 150:1530–1535. 2009. View Article : Google Scholar
10	Hsu LJ, Schultz L, Hong Q, et al: Transforming growth factor beta1 signaling via interaction with cell surface Hyal-2 and recruitment of WWOX/WOX1. J Biol Chem. 284:16049–16059. 2009. View Article : Google Scholar : PubMed/NCBI
11	Aqeilan RI, Pekarsky Y, Herrero JJ, et al: Functional association between Wwox tumor suppressor protein and p73, a p53 homolog. Proc Natl Acad Sci USA. 101:4401–4406. 2004. View Article : Google Scholar : PubMed/NCBI
12	Gaudio E, Palamarchuk A, Palumbo T, et al: Physical association with WWOX suppresses c-Jun transcriptional activity. Cancer Res. 66:11585–11589. 2006. View Article : Google Scholar : PubMed/NCBI
13	Li MY, Lai FJ, Hsu LJ, et al: Dramatic co-activation of WWOX/WOX1 with CREB and NF-kappaB in delayed loss of small dorsal root ganglion neurons upon sciatic nerve transection in rats. PLoS One. 4:e78202009. View Article : Google Scholar : PubMed/NCBI
14	Guo W, Wang G, Dong Y, Guo Y, Kuang G and Dong Z: Decreased expression of WWOX in the development of esophageal squamous cell carcinoma. Mol Carcinog. Dec 27–2011.(Epub ahead of print). View Article : Google Scholar
15	Maeda N, Semba S, Nakayama S, Yanagihara K and Yokozaki H: Loss of WW domain-containing oxidoreductase expression in the progression and development of gastric carcinoma: clinical and histopathologic correlations. Virchows Arch. 457:423–432. 2010. View Article : Google Scholar
16	Kuroki T, Yendamuri S, Trapasso F, et al: The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. Clin Cancer Res. 10:2459–2465. 2004. View Article : Google Scholar : PubMed/NCBI
17	Donati V, Fontanini G, Dell’Omodarme M, et al: WWOX expression in different histologic types and subtypes of non-small cell lung cancer. Clin Cancer Res. 13:884–891. 2007. View Article : Google Scholar : PubMed/NCBI
18	Giarnieri E, Zanesi N, Bottoni A, et al: Oncosuppressor proteins of fragile sites are reduced in cervical cancer. Cancer Lett. 289:40–45. 2010. View Article : Google Scholar : PubMed/NCBI
19	Guler G, Uner A, Guler N, et al: The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma. Cancer. 100:1605–1614. 2004. View Article : Google Scholar : PubMed/NCBI
20	Kurek KC, Del Mare S, Salah Z, et al: Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression. Cancer Res. 70:5577–5586. 2010. View Article : Google Scholar : PubMed/NCBI
21	Porter AG and Jänicke RU: Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999. View Article : Google Scholar : PubMed/NCBI
22	Kerr JF, Wyllie AH and Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:239–257. 1972. View Article : Google Scholar : PubMed/NCBI
23	Evan G and Littlewood T: A matter of life and cell death. Science. 281:1317–1322. 1998. View Article : Google Scholar : PubMed/NCBI
24	Arnoult D, Gaume B, Karbowski M, Sharpe JC, Cecconi F and Youle RJ: Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J. 22:4385–4399. 2003. View Article : Google Scholar : PubMed/NCBI
25	Liu X, Kim CN, Yang J, Jemmerson R and Wang X: Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86:147–157. 1996. View Article : Google Scholar : PubMed/NCBI
26	Zou H, Henzel WJ, Liu X, Lutschg A and Wang X: Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 90:405–413. 1997.PubMed/NCBI
27	Hu BS, Tan JW, Zhu GH, Wang DF, Zhou X and Sun ZQ: WWOX induces apoptosis and inhibits proliferation of human hepatoma cell line SMMC-7721. World J Gastroenterol. 18:3020–3026. 2012. View Article : Google Scholar : PubMed/NCBI
28	Zhang P, Jia R, Ying L, et al: WWOX-mediated apoptosis in A549 cells mainly involves the mitochondrial pathway. Mol Med Rep. 6:121–124. 2012.PubMed/NCBI
29	Chiang MF, Yeh ST, Liao HF, Chang NS and Chen YJ: Overexpression of WW domain-containing oxidoreductase WOX1 preferentially induces apoptosis in human glioblastoma cells harboring mutant p53. Biomed Pharmacother. 66:433–438. 2012. View Article : Google Scholar
30	Finnis M, Dayan S, Hobson L, et al: Common chromosomal fragile site FRA16D mutation in cancer cells. Hum Mol Genet. 14:1341–1349. 2005. View Article : Google Scholar : PubMed/NCBI
31	Jee KJ, Kim YT, Kim KR, Aalto Y and Knuutila S: Amplification at 9p in cervical carcinoma by comparative genomic hybridization. Anal Cell Pathol. 22:159–163. 2001. View Article : Google Scholar : PubMed/NCBI
32	Tsuda H, Takarabe T, Okada S, et al: Different pattern of loss of heterozygosity among endocervical-type adenocarcinoma, endometrioid-type adenocarcinoma and adenoma malignum of the uterine cervix. Int J Cancer. 98:713–717. 2002. View Article : Google Scholar
33	Cullen AP, Reid R, Campion M and Lörincz AT: Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol. 65:606–612. 1991.PubMed/NCBI
34	Hopman AH, Smedts F, Dignef W, et al: Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J Pathol. 202:23–33. 2004. View Article : Google Scholar
35	Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ and Vousden KH: Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Lancet. 339:1070–1073. 1992. View Article : Google Scholar : PubMed/NCBI